A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test that shows how blood flows to tissues and organs. Nuclear imaging requires small amounts of radioactive materials called radiopharmaceuticals – injected, inhaled or swallowed – to diagnose disease. SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, In-111，and other SPECT isotopes.

Scope of the Report:

The worldwide market for SPECT Radiopharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new research study.

This report focuses on the SPECT Radiopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

GE Healthcare

Cardinal Health

Lantheus Medical Imaging

Bracco Imaging

Eczacibasi-Monrol Nuclear Products

IBA Molecular Imaging

Jubilant Life Sciences

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Technetium-99

Thallium-201

Gallium-67

Iodine-123

Indium-111

Other

Market Segment by Applications, can be divided into

Oncology

Cardiology

Thyroid

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe SPECT Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of SPECT Radiopharmaceuticals, with price, sales, revenue and global market share of SPECT Radiopharmaceuticals in 2017 and 2018.

Chapter 3, the SPECT Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the SPECT Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, SPECT Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe SPECT Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview

1.1 SPECT Radiopharmaceuticals Introduction

1.2 Market Analysis by Type

1.2.1 Technetium-99

1.2.2 Thallium-201

1.2.3 Gallium-67

1.2.4 Iodine-123

1.2.5 Indium-111

1.2.6 Other

1.3 Market Analysis by Applications

1.3.1 Oncology

1.3.2 Cardiology

1.3.3 Thyroid

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 GE Healthcare

2.1.1 Business Overview

2.1.2 SPECT Radiopharmaceuticals Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GE Healthcare SPECT Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Cardinal Health

2.2.1 Business Overview

2.2.2 SPECT Radiopharmaceuticals Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Cardinal Health SPECT Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Lantheus Medical Imaging

2.3.1 Business Overview

2.3.2 SPECT Radiopharmaceuticals Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Bracco Imaging

2.4.1 Business Overview

2.4.2 SPECT Radiopharmaceuticals Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bracco Imaging SPECT Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Eczacibasi-Monrol Nuclear Products

2.5.1 Business Overview

2.5.2 SPECT Radiopharmaceuticals Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 IBA Molecular Imaging

2.6.1 Business Overview

2.6.2 SPECT Radiopharmaceuticals Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Jubilant Life Sciences

2.7.1 Business Overview

2.7.2 SPECT Radiopharmaceuticals Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Jubilant Life Sciences SPECT Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global SPECT Radiopharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global SPECT Radiopharmaceuticals Sales and Market Share by Manufacturer (2017-2018)

3.2 Global SPECT Radiopharmaceuticals Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 SPECT Radiopharmaceuticals Manufacturer Market Share in 2018

3.3.2 Top 6 SPECT Radiopharmaceuticals Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global SPECT Radiopharmaceuticals Market Analysis by Regions

4.1 Global SPECT Radiopharmaceuticals Sales, Revenue and Market Share by Regions

4.1.1 Global SPECT Radiopharmaceuticals Sales and Market Share by Regions (2014-2019)

4.1.2 Global SPECT Radiopharmaceuticals Revenue and Market Share by Regions (2014-2019)

4.2 North America SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

4.3 Europe SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

4.5 South America SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

5 North America SPECT Radiopharmaceuticals by Country

5.1 North America SPECT Radiopharmaceuticals Sales, Revenue and Market Share by Country

5.1.1 North America SPECT Radiopharmaceuticals Sales and Market Share by Country (2014-2019)

5.1.2 North America SPECT Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)

5.2 United States SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

5.3 Canada SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

5.4 Mexico SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

6 Europe SPECT Radiopharmaceuticals by Country

6.1 Europe SPECT Radiopharmaceuticals Sales, Revenue and Market Share by Country

6.1.1 Europe SPECT Radiopharmaceuticals Sales and Market Share by Country (2014-2019)

6.1.2 Europe SPECT Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)

6.2 Germany SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

6.3 UK SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

6.4 France SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

6.5 Russia SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

6.6 Italy SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

7 Asia-Pacific SPECT Radiopharmaceuticals by Country

7.1 Asia-Pacific SPECT Radiopharmaceuticals Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific SPECT Radiopharmaceuticals Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific SPECT Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)

7.2 China SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

7.3 Japan SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

7.4 Korea SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

7.5 India SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

7.6 Southeast Asia SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

8 South America SPECT Radiopharmaceuticals by Country

8.1 South America SPECT Radiopharmaceuticals Sales, Revenue and Market Share by Country

8.1.1 South America SPECT Radiopharmaceuticals Sales and Market Share by Country (2014-2019)

8.1.2 South America SPECT Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)

8.2 Brazil SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

8.3 Argentina SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

8.4 Colombia SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

9 Middle East and Africa SPECT Radiopharmaceuticals by Countries

9.1 Middle East and Africa SPECT Radiopharmaceuticals Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa SPECT Radiopharmaceuticals Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa SPECT Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

9.3 Turkey SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

9.4 Egypt SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

9.5 Nigeria SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

9.6 South Africa SPECT Radiopharmaceuticals Sales and Growth Rate (2014-2019)

10 Global SPECT Radiopharmaceuticals Market Segment by Type

10.1 Global SPECT Radiopharmaceuticals Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global SPECT Radiopharmaceuticals Sales and Market Share by Type (2014-2019)

10.1.2 Global SPECT Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)

10.2 Technetium-99 Sales Growth and Price

10.2.1 Global Technetium-99 Sales Growth (2014-2019)

10.2.2 Global Technetium-99 Price (2014-2019)

10.3 Thallium-201 Sales Growth and Price

10.3.1 Global Thallium-201 Sales Growth (2014-2019)

10.3.2 Global Thallium-201 Price (2014-2019)

10.4 Gallium-67 Sales Growth and Price

10.4.1 Global Gallium-67 Sales Growth (2014-2019)

10.4.2 Global Gallium-67 Price (2014-2019)

10.5 Iodine-123 Sales Growth and Price

10.5.1 Global Iodine-123 Sales Growth (2014-2019)

10.5.2 Global Iodine-123 Price (2014-2019)

10.6 Indium-111 Sales Growth and Price

10.6.1 Global Indium-111 Sales Growth (2014-2019)

10.6.2 Global Indium-111 Price (2014-2019)

10.7 Other Sales Growth and Price

10.7.1 Global Other Sales Growth (2014-2019)

10.7.2 Global Other Price (2014-2019)

11 Global SPECT Radiopharmaceuticals Market Segment by Application

11.1 Global SPECT Radiopharmaceuticals Sales Market Share by Application (2014-2019)

11.2 Oncology Sales Growth (2014-2019)

11.3 Cardiology Sales Growth (2014-2019)

11.4 Thyroid Sales Growth (2014-2019)

12 SPECT Radiopharmaceuticals Market Forecast (2019-2024)

12.1 Global SPECT Radiopharmaceuticals Sales, Revenue and Growth Rate (2019-2024)

12.2 SPECT Radiopharmaceuticals Market Forecast by Regions (2019-2024)

12.2.1 North America SPECT Radiopharmaceuticals Market Forecast (2019-2024)

12.2.2 Europe SPECT Radiopharmaceuticals Market Forecast (2019-2024)

12.2.3 Asia-Pacific SPECT Radiopharmaceuticals Market Forecast (2019-2024)

12.2.4 South America SPECT Radiopharmaceuticals Market Forecast (2019-2024)

12.2.5 Middle East and Africa SPECT Radiopharmaceuticals Market Forecast (2019-2024)

12.3 SPECT Radiopharmaceuticals Market Forecast by Type (2019-2024)

12.3.1 Global SPECT Radiopharmaceuticals Sales Forecast by Type (2019-2024)

12.3.2 Global SPECT Radiopharmaceuticals Market Share Forecast by Type (2019-2024)

12.4 SPECT Radiopharmaceuticals Market Forecast by Application (2019-2024)

12.4.1 Global SPECT Radiopharmaceuticals Sales Forecast by Application (2019-2024)

12.4.2 Global SPECT Radiopharmaceuticals Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure SPECT Radiopharmaceuticals Picture

Table Product Specifications of SPECT Radiopharmaceuticals

Figure Global Sales Market Share of SPECT Radiopharmaceuticals by Types